الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 110 |  |  |
| | | from | 110 | | |
Abstract
With over 250 million cases and 5 million deaths recorded worldwide so far, the COVID-19 pandemic caused by SARS-CoV-2 is an ongoing global crisis. COVID-19 presentation is highly varied. An estimated 17%–20% of those infected remain asymptomatic, while others can develop a mild-to-moderate disease or severe pneumonia.
According to WHO, ‘loss of smell or taste’ is considered a less common symptom of COVID-19. However, findings from many studies conducted worldwide have strongly contradicted this, with several reports depicting high prevalence of olfactory and/or gustatory dysfunction (OD ±GD) among infected subjects.
The aim was to improve quality of life in post COVID patients by assessing prevalence of anosmia and Smell Dysfunctions and their impact on quality of life Port Fouad general hospital in Port Said Governorate.